ArticlePloS one2017

Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.

Hui Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.